Bruker acquires biocrates life sciences, terms undisclosed

Bruker (BRKR) announced the acquisition of biocrates life sciences, located in Innsbruck, Austria. Financial terms were not disclosed. “Our acquisition of biocrates represents a pivotal step in our ambitious metabolomics and lipidomics growth plans,” said Matt Lewis, Bruker VP, metabolomics and lipidomics. “By leveraging biocrates’ expertise in quantitation and workflow automation, we accelerate the impact of MS-based omics to revolutionize and advance a shared multiomics vision.”